News Search Results
Jul 16, 2025, 06:30 ET Deerfield Group Acquires Triple Threat Communications to Enhance Healthcare Marketing Strategy and Creative Offerings
GroupDeerfield Group is a full-service integrated marketing, advertising, and communications agency providing innovative solutions for pharmaceutical, biotechnology, health tech, and consumer health companies. Deerfield's solutions are designed to meet the unique needs of healthcare
More news about: Deerfield Group
Jul 16, 2025, 03:14 ET TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic
More news about: TFS HealthScience
Jul 16, 2025, 02:56 ET TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic
More news about: TFS HealthScience
Jul 15, 2025, 22:32 ET Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors
first-in-class molecule targeting novel cancer mechanisms, but also reflects international recognition of Taiwan's biotechnology achievements. This strengthens the company's visibility and strategic position on the global stage in oncology drug development. Trial
More news about: Senhwa Biosciences, Inc.
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
Scripps Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions. For more information, please visit:
More news about: Arkbio
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
Scripps Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions. For more information, please visit:
More news about: Arkbio
Jul 15, 2025, 18:17 ET BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jul 15, 2025, 16:06 ET ATTENTION NASDAQ: RCKT INVESTORS: Contact Berger Montague About a Rocket Pharmaceuticals Class Action Lawsuit
Rocket Pharmaceuticals, headquartered in Cranbury, New Jersey, is a biotechnology company focused on developing gene therapies for rare diseases. The suit alleges that the Company failed to inform investors
More news about: Berger Montague
Jul 15, 2025, 11:30 ET Optical Measuring Machine Market Size Grows to USD 4.63 Billion by 2031 | CAGR of 7.3% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 15, 2025, 11:00 ET Room AC Market Size expected to reach US$78.60 billion by 2031 | CAGR of 6.1% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 15, 2025, 10:30 ET Atomic Force Microscopy Market worth $762.2 million by 2030 - Exclusive Report by MarketsandMarkets™
data analysis software, which enhances precision and enables multi-dimensional surface characterization in semiconductors, materials science, and biotechnology industries. Moreover, the shift toward high-resolution, non-destructive testing methods accelerates AFM adoption, especially in quality control
More news about: MarketsandMarkets
Jul 15, 2025, 09:50 ET Faruqi & Faruqi Reminds Fortrea Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 - FTRE
from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are "not as material as [o]ne [m]ight think," stating
More news about: Faruqi & Faruqi, LLP
Jul 15, 2025, 09:33 ET Made Scientific and Sentinel BioTherapeutics Announce Strategic Manufacturing Partnership to Advance Ph I/II Allogeneic ePP Encapsulated Cell Therapy Program
South Korea, a world leader in pharmaceuticals and biotechnology. About Sentinel BioTherapeuticsSentinel BioTherapeutics, a portfolio company of RBL LLC, is a clinical-stage biotechnology company pioneering localized immune-modulating therapies for tumors that
More news about: Made Scientific, Inc.
Jul 15, 2025, 09:00 ET SPRIM PRO and ObvioHealth Expand Collaboration to Deliver Digitally Enabled Trials with Scientific Rigor and Global Reach
scientifically powered global boutique CRO with custom solutions that are designed to accommodate all types of clinical trials in biopharmaceutical, biotechnology, medical device/digital therapeutic, infant formula and nutrition, and consumer health industries. SPRIM PRO delivers high-quality clinical trial
More news about: ObvioHealth
Jul 15, 2025, 08:59 ET Immorta Bio, a Scientific Longevity Company, Appoints Pharmaceutical Industry Veteran Dr. Armin Rath as Chief Business Officer
Fla., July 15, 2025 /PRNewswire/ -- Immorta Bio, Inc., a cutting-edge biotechnology company pioneering the science of longevity and committed to "Treating Diseases of Aging and Treating Aging as a Disease™," today announced
More news about: Immorta Bio Inc.
Jul 15, 2025, 08:03 ET Food Supply Security Becomes QuantiPath Under Bold Rebrand
weeks to support engagement and education leading up to the commercial release of GenoPATHx. About QuantiPathQuantiPath is a biotechnology company revolutionizing food safety testing through precision genetic diagnostics. Its flagship product, GenoPATHx, is the only rapid test
More news about: QuantiPath
Jul 15, 2025, 08:01 ET Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for Oncology and other indications, today announced
More news about: Aethlon Medical, Inc.
Jul 15, 2025, 08:00 ET Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jul 15, 2025, 07:30 ET Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Jul 15, 2025, 07:00 ET Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
BOSTON, July 15, 2025 /PRNewswire/ -- Tract Bio, a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced the appointment of Chris
More news about: Tract Bio
Jul 14, 2025, 19:00 ET Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
semaglutide (0.5 mg, once-weekly) via SQ injection. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Jul 14, 2025, 17:31 ET MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight
Palatin Technologies, Inc., Aldeyra Therapeutics, Inc., ReGenTree, RegeneRx Biopharmaceuticals, Inc., Mimetogen, Alcon, Aerie Pharmaceuticals, BRIM Biotechnology, Inc., Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis, S.A., PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll BioPharma
More news about: DelveInsight Business Research, LLP
Jul 14, 2025, 14:50 ET LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jul 14, 2025, 14:37 ET LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jul 14, 2025, 13:03 ET Kalorama Information's 2025 IVD Atlas Tracks Global Growth Hotspots, Led by China and Emerging Markets
Information has been a trusted publisher of healthcare market research for over 25 years. Its analysts specialize in in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests,
More news about: Kalorama Information